FI913407A - NYA PURINDERIVAT. - Google Patents

NYA PURINDERIVAT. Download PDF

Info

Publication number
FI913407A
FI913407A FI913407A FI913407A FI913407A FI 913407 A FI913407 A FI 913407A FI 913407 A FI913407 A FI 913407A FI 913407 A FI913407 A FI 913407A FI 913407 A FI913407 A FI 913407A
Authority
FI
Finland
Prior art keywords
purinderivat
nya
nya purinderivat
Prior art date
Application number
FI913407A
Other languages
Finnish (fi)
Other versions
FI913407A0 (en
Inventor
Roland Jaunin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI913407A0 publication Critical patent/FI913407A0/en
Publication of FI913407A publication Critical patent/FI913407A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI913407A 1990-07-18 1991-07-15 NYA PURINDERIVAT. FI913407A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH238790 1990-07-18

Publications (2)

Publication Number Publication Date
FI913407A0 FI913407A0 (en) 1991-07-15
FI913407A true FI913407A (en) 1992-01-19

Family

ID=4232597

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913407A FI913407A (en) 1990-07-18 1991-07-15 NYA PURINDERIVAT.

Country Status (13)

Country Link
EP (1) EP0467207A3 (en)
JP (1) JPH04234391A (en)
KR (1) KR920002600A (en)
AU (1) AU8038491A (en)
CA (1) CA2044806A1 (en)
FI (1) FI913407A (en)
HU (1) HU209591B (en)
IE (1) IE912500A1 (en)
IL (1) IL98812A0 (en)
MC (1) MC2278A1 (en)
NO (1) NO912804L (en)
PT (1) PT98348A (en)
ZA (1) ZA915418B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
US5202328A (en) * 1991-03-06 1993-04-13 Merck & Co., Inc. Substituted fused pyrimidinones
TW274551B (en) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
SE9903028D0 (en) 1999-08-27 1999-08-27 Astra Ab New use
PE20030008A1 (en) 2001-06-19 2003-01-22 Bristol Myers Squibb Co DUAL INHIBITORS OF PDE 7 AND PDE 4
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (en) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER and OTHER DISORDERS.
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
IL96019A0 (en) * 1989-10-31 1991-07-18 Fujisawa Pharmaceutical Co Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use

Also Published As

Publication number Publication date
JPH04234391A (en) 1992-08-24
EP0467207A3 (en) 1992-08-12
HUT58736A (en) 1992-03-30
NO912804L (en) 1992-01-20
EP0467207A2 (en) 1992-01-22
HU209591B (en) 1994-08-29
KR920002600A (en) 1992-02-28
CA2044806A1 (en) 1992-01-19
ZA915418B (en) 1992-03-25
IE912500A1 (en) 1992-01-29
NO912804D0 (en) 1991-07-17
IL98812A0 (en) 1992-07-15
HU912347D0 (en) 1991-12-30
MC2278A1 (en) 1993-06-23
AU8038491A (en) 1992-01-23
PT98348A (en) 1992-05-29
FI913407A0 (en) 1991-07-15

Similar Documents

Publication Publication Date Title
FI924077A0 (en) NYA OMAETTADE ACYKLISKA PURIN- OCH PYRIMIDINPHOSPHONATDERIVAT.
FI913963A0 (en) NYA BENSIMIDAZOLDERIVAT.
FI921135A0 (en) NYA CARBONSYRAMIDE.
FI930381A0 (en) NYA VAERMESTABILA PULLULANASER
FI924672A0 (en) NYA ANTIMICROBIELLA QUINOLONTIOUREAS
FI920279A (en) NYA SULFONYLUREA-FOERENINGAR.
FI913533A (en) NYA CARBOCYCLIS ANALOGER AV VISSA NUCLEOSIDER.
FI902780A0 (en) NYA POLY-A-OLEFINER.
FI915400A (en) NYA TRICYCLISKA FOERENINGAR.
FI906334A (en) NYA E-VITAMINDERIVAT OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV.
FI914319A (en) NYA KARBOCYKLISKA ADENOSINANALOGER ANVAENDBARA SOM IMMUNOSUPRESSANTER.
FI921614A0 (en) NYA HERBICIDER.
FI923872A0 (en) NYA BENSOPYRANDERIVAT.
FI913407A (en) NYA PURINDERIVAT.
FI923762A0 (en) NYA HEPARINDERIVAT.
FI914071A (en) NYA HETRAZEPINOID AMIDER.
FI932928A (en) NYA BENZENSIAZEPINDERIVAT
FI902602A0 (en) NYA FOERENINGAR.
FI922552A0 (en) NYA KEFEMFOERENINGAR.
FI912317A0 (en) NYA TRICYCLISKA FOERENINGAR.
FI911351A (en) NYA 8-SULPHAMYLMETHYLENE-2-AMINOTETRALINER.
FI904903A0 (en) NYA FOERENINGAR.
FI915935A0 (en) NYA CYKLODEXTRININKLUSIONSKOMPLEXER.
FI911508A0 (en) NYA ISOKROMANDERIVAT.
FI901137A0 (en) NYA FOERENINGAR.

Legal Events

Date Code Title Description
FD Application lapsed